216 related articles for article (PubMed ID: 16759642)
21. Antithrombin III prevents cerulein-induced acute pancreatitis in rats.
Hagiwara S; Iwasaka H; Shingu C; Matsumoto S; Uchida T; Noguchi T
Pancreas; 2009 Oct; 38(7):746-51. PubMed ID: 19546838
[TBL] [Abstract][Full Text] [Related]
22. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
23. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
24. Effects of the phosphodiesterase IV inhibitor rolipram on Th1 and Th2 immune responses in mice.
Yamaki K; Li X; Uchida H; Alam AH; Hossain MA; Yanagisawa R; Takano H; Taneda S; Hayashi H; Mori Y; Yoshino S
J Pharm Pharmacol; 2004 Jul; 56(7):877-82. PubMed ID: 15233866
[TBL] [Abstract][Full Text] [Related]
25. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.
Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S
Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620
[TBL] [Abstract][Full Text] [Related]
26. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
[TBL] [Abstract][Full Text] [Related]
27. Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model.
Sato Y; Hiramatsu Y; Homma S; Sato S; Onizuka M; Sakakibara Y
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):172-7. PubMed ID: 12539001
[TBL] [Abstract][Full Text] [Related]
28. The selective inhibition of type IV phosphodiesterase attenuates the severity of the acute pancreatitis in rats.
Mersin H; İrkin F; Berberoglu U; Gülben K; Özdemir H; Öngürü Ö
Dig Dis Sci; 2009 Dec; 54(12):2577-82. PubMed ID: 19117125
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation.
Sato Y; Hiramatsu Y; Homma S; Sato M; Sato S; Endo S; Sohara Y
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):346-50. PubMed ID: 16077397
[TBL] [Abstract][Full Text] [Related]
30. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats.
Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M
Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064
[TBL] [Abstract][Full Text] [Related]
31. Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors among rats, monkeys and humans.
Bian H; Zhang J; Wu P; Varty LA; Jia Y; Mayhood T; Hey JA; Wang P
Biochem Pharmacol; 2004 Dec; 68(11):2229-36. PubMed ID: 15498513
[TBL] [Abstract][Full Text] [Related]
32. Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in rats.
Noble MD; Romac J; Wang Y; Hsu J; Humphrey JE; Liddle RA
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G128-34. PubMed ID: 16769810
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2007 Mar; 559(2-3):219-26. PubMed ID: 17250824
[TBL] [Abstract][Full Text] [Related]
34. IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis.
Warzecha Z; Dembinski A; Ceranowicz P; Konturek SJ; Tomaszewska R; Stachura J; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):575-90. PubMed ID: 14726612
[TBL] [Abstract][Full Text] [Related]
35. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
[TBL] [Abstract][Full Text] [Related]
36. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2006 Nov; 550(1-3):166-72. PubMed ID: 17010967
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis.
Francischi JN; Yokoro CM; Poole S; Tafuri WL; Cunha FQ; Teixeira MM
Eur J Pharmacol; 2000 Jul; 399(2-3):243-9. PubMed ID: 10884526
[TBL] [Abstract][Full Text] [Related]
39. Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
Imahashi K; Yoshioka J; Yamakita T; Yamano S; Kusuoka H; Nishimura T
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):290-1. PubMed ID: 11251642
[TBL] [Abstract][Full Text] [Related]
40. The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation.
Sebastiani G; Morissette C; Lagacé C; Boulé M; Ouellette MJ; McLaughlin RW; Lacombe D; Gervais F; Tremblay P
Neurobiol Aging; 2006 May; 27(5):691-701. PubMed ID: 15993984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
